Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD
Therapeutic Advances in Gastroenterology · 2026-07 · 19
DOI: 10.1177/17562848261465720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Gastroenterology, online erschienen am 31.07.2026. Verfasst von Honglu Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Dalian Medical University), Shenyang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: department of science and technology of liaoning province, Independent Research Funding of General Hospital of Northern Theater Command.
Abstract (Originalsprache)
Background
The association of Helicobacter pylori ( H. pylori ) infection with non-alcoholic fatty liver disease (NAFLD) remains controversial. Additionally, its associations with metabolic dysfunction-associated fatty liver disease (MAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), and Chinese MAFLD using the most recent diagnostic criteria were unclear.
Objective
To analyze the associations of H. pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD.
Design
Cross-sectional study.
Methods
This study screened 1172 inpatients who underwent both H. pylori test and liver computed tomography or ultrasound examination between June 2020 and May 2024. Multivariate Logistic regression analyses were performed to evaluate the associations of H. pylori infection with the severity of hepatic steatosis and risk of hepatic fibrosis. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were calculated after adjusting for gender, hypertension, hyperlipidemia, body mass index (BMI), fasting plasma glucose (FPG), and high-sensitivity C-reactive protein (HsCRP) in NAFLD analyses; age, gender, drinking, hypertension, diabetes, hyperlipidemia, BMI, and HsCRP in MAFLD analyses; and gender, drinking, hypertension, hyperlipidemia, BMI, FPG, and HsCRP in MASLD and Chinese MAFLD analyses.
Results
Overall, 875, 982, 869, and 869 patients were included in NAFLD, MAFLD, MASLD, and Chinese MAFLD analyses, respectively. In NAFLD, MAFLD, MASLD, and Chinese MAFLD analyses, 257, 302, 257, and 257 patients had H. pylori infection, respectively. H. pylori infection was independently associated with severe hepatic steatosis in NAFLD (aOR = 3.956; 95% CI = 1.171–13.359, p = 0.027), MAFLD (aOR = 3.730; 95% CI = 1.083–12.850, p = 0.037), and MASLD (aOR = 3.962; 95% CI = 1.158–13.557, p = 0.028) analyses, but not Chinese MAFLD analyses. However, H. pylori infection was not independently associated with the risk of hepatic fibrosis.
Conclusion
H. pylori infection may increase the severity of NAFLD, MAFLD, and MASLD, but not the risk of liver fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Dalian Medical University), Shenyang, China.
- Postgraduate College, Dalian Medical University, Dalian, China.
- Anju District People's Hospital of Sui Ning, Suining, China.
- Department of Gastroenterology, General Hospital of Northern Theater Command, No. 83 Wenhua Road, Shenyang, Liaoning Province 110840, China.
- Liver Research Unit, Medica Sur Clinic and Foundation, National Autonomous University of Mexico, Mexico City 14050, Mexico.
ORCID-Profile: Xingshun Qi
Förderung
- department of science and technology of liaoning province
- Independent Research Funding of General Hospital of Northern Theater Command
Zitieren
APA
Yu, H., Gao, Y., Wang, X., Chen, L., Zhang, Y., Li, H., Méndez-Sánchez, N., & Qi, X. (2026). Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD. Therapeutic Advances in Gastroenterology, 19. https://doi.org/10.1177/17562848261465720
Vancouver
Yu H, Gao Y, Wang X, Chen L, Zhang Y, Li H, et al. Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD. Therapeutic Advances in Gastroenterology. 2026;19. doi:10.1177/17562848261465720
BibTeX
@article{Yu2026,
author = {Yu, Honglu and Gao, Yuting and Wang, Xiaomin and Chen, Lan and Zhang, Yongguo and Li, Hongyu and Méndez-Sánchez, Nahum and Qi, Xingshun},
title = {Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD},
journal = {Therapeutic Advances in Gastroenterology},
year = {2026},
volume = {19},
doi = {10.1177/17562848261465720}
}
EUVIMED